Follow the CONDUIT PHARMACEUTICALS INC. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €822m. The latest transaction was reported on 13 June 2025 (Attribution). Among the most active insiders: Farley Chele Chiavacci. The full history is accessible without an account.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€251,334
3 ops.
Sell Volume
30Σ signal
Buys n/a€251,334 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 74 of 29,024 companies
91.5
score / 100
Value
96
Quality
87
FCF yld44%
Earn yld14%
EV/EBITDA3.9x
ROE20%
Gross mgn·
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CONDUIT PHARMACEUTICALS INC. is a company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker XNAS.